Nicotine metabolism by the polymorphic cytochrome P450 2A6 (CYP2A6) enzyme: Implications for interindividual differences in smoking behaviour target article on nicotine-addiction

被引：0
|
作者：
Oscarson, M [1 ]
机构：
[1] Karolinska Inst, Div Mol Toxicol, Natl Inst Environm Med, SE-17177 Stockholm, Sweden
来源：
PSYCOLOQUY | 2001年 / 12卷 / 03期
关键词：
nicotine; cytochrome P450; CYP2A6; drug metabolism; genetic polymorphism; genotype; phenotype;
D O I：
暂无
中图分类号：
B84 [心理学];
学科分类号：
04 ; 0402 ;
摘要：
Cytochrome P450 2A6 (CYP2A6) is one of the most important enzymes in human nicotine metabolism. Genetic polymorphisms in the CYP2A6 gene causes important interindividual variability in CYP2A6 activity and this variation can explain some of the interindividual variability in nicotine metabolism previously reported. Here I summarise the current knowledge about the CYP2A6 polymorphism, and also discuss the potential importance of this polymorphism for differences in smoking behaviour.
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [31] Pathogenic Missense Mutations in Nicotine-metabolizing Cytochrome P450 2A6 Gene - An In silico Study
    Venkadesan, Kalaivani
    Leelavathi, L.
    Priyadharsini, J. Vijayashree
    Arumugham, I. Meignana
    Kumar, S. Rajesh
    JOURNAL OF THE INTERNATIONAL CLINICAL DENTAL RESEARCH ORGANIZATION, 2024, 16 (01) : 55 - 65
  • [32] Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA:: Implications for post-transcriptional regulation of the CYP2A6 gene
    Christian, K
    Lang, M
    Maurel, P
    Raffalli-Mathieu, F
    MOLECULAR PHARMACOLOGY, 2004, 65 (06) : 1405 - 1414
  • [33] Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
    Malaiyandi, V
    Lerman, C
    Benowitz, NL
    Jepson, C
    Patterson, F
    Tyndale, RF
    MOLECULAR PSYCHIATRY, 2006, 11 (04) : 400 - 409
  • [34] Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy
    V Malaiyandi
    C Lerman
    N L Benowitz
    C Jepson
    F Patterson
    R F Tyndale
    Molecular Psychiatry, 2006, 11 : 400 - 409
  • [35] Cytochrome P450 2A6 mediated metabolism of b-nicotyrine
    Kramlinger, Valerie M.
    Murphy, Sharon E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [36] Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review
    Jones, Stephanie K.
    Wolf, Bethany J.
    Froeliger, Brett
    Wallace, Kristin
    Carpenter, Matthew J.
    Alberg, Anthony J.
    NICOTINE & TOBACCO RESEARCH, 2022, 24 (05) : 633 - 642
  • [37] IN VITRO STUDY OF MODULATORY EFFECTS OF EXTRACTS OF STROBILANTHES CRISPUS ON HUMAN CDNA-EXPRESSED CYTOCHROME P450 2A6 (CYP2A6)
    Yan, Pan
    Koh, Rhun Yian
    Ong, Chin Eng
    Chieng, Jin Yu
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S67 - S67
  • [38] Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations
    Nakajima, Miki
    Fukami, Tatsuki
    Yamanaka, Hiroyuki
    Higashi, Eriko
    Sakai, Haruko
    Yoshida, Ryoko
    Kwon, Jun-Tack
    McLeod, Howard L.
    Yokoi, Tsuyoshi
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 282 - 297
  • [39] THE NATURAL PRODUCT 2-METHOXY TRANS-CINNAMALDEHYDE IS A TIME DEPENDENT INHIBITOR OF THE NICOTINE AND LETROZOLE METABOLIZING ENZYME CYTOCHROME P450 2A6
    Espiritu, Michael
    Larkin, Michael
    True, Heather
    Chan, Jeannine
    Stamper, Brendan
    Harrelson, John
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S69 - S69
  • [40] Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians
    Schoedel, KA
    Hoffmann, EB
    Rao, Y
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS, 2004, 14 (09): : 615 - 626
12345